Biochips Deep Research on Industrial and Market studies, (Type: DNA Chips, Protein Chips, Microfluidic Devices; Application: Drug Discovery & Development, Genomics, Proteomics and In Vitro Diagnostics) - Global Industry Analysis, Size, Share, Growth, Tren

"Biochips Market, (Type: DNA Chips, Protein Chips, Microfluidic Devices; Application: Drug Discovery & Development, Genomics, Proteomics and In Vitro Diagnostics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

This market research study analyzes the biochips market on global basis and provides estimates in terms of revenue (USD million) from 2014 to 2023. It describes the market dynamics affecting the industry and analyzes their impact through the forecast period. Moreover, it highlights the significant opportunities for market growth in the next eight years. 

Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=713929

Biochips are a collection of microarrays which are arranged on a solid substrate that enables numerous biochemical reactions such as decoding of genes in a few seconds. In addition, biochips are designed to function in biological environments and are capable of detecting and measuring a large number of biomarkers and perform complex biochemical reactions simultaneously in a very short span of time. There have been considerable advancements in the biotechnology industry on account of the increasing application of biochips.

In addition, biochips are largely used for research in drug discovery and development, genomics, proteomics, and molecular diagnostics. Biochips help in analyzing organic molecules related to living organisms. Therefore, they help in detecting gene sequences, environmental pollutants, airborne toxins, and other biochemical constituents. 

Increasing application of biochips in the medical sector for cancer treatment, drug research, and diagnostics is one of the major factors driving the growth of the global biochips market. In addition, factors such as availability of molecular information, automation of biochemical processes through the use of biochips and application of biochips for gene and protein identification are set to drive the global biochips market. 

The use of biochips has brought about a transition in the field of drug discovery and research. Biochips have the ability to detect cancer before its symptoms develop in human bodies. In addition, it can easily detect virulent diseases such as smallpox, anthrax, and plague in a very short span of time. Moreover, biochips are increasingly finding application in veterinary diagnostics. Biochips comprise grids that may be dots or small wells. Each grid contains nucleic acid or antibodies and proteins which bind to a DNA sequence or a target antigen. The abundance of proteomics and genetics data coupled with the need for identifying gene sequences and proteins in human beings is driving the biochips market. Conventional gene and protein sequencing methods cannot provide qualitative output and are ineffective whereas biochips are extremely effective and produce accurate gene sequencing results in a very short span of time. 

Significant growth in the healthcare sector, rising demands for diagnostics and increasing medical expenditure coupled with economic reforms in major developing countries has been able to bolster the growth of this market. Asia Pacific and Rest of the World (RoW) are key markets for the future and are expected to provide huge opportunities to the global biochips manufacturers. 

The market is segmented on the basis of geography into Europe, North America, Asia Pacific and Rest of the World (RoW). These segments have been estimated in terms of revenue (USD million). In addition, the report has been segmented based on types, which includes DNA chips, protein chips and microfluidic devices. In addition, the report is also segmented by application that includes drug discovery & development, genomics, proteomics and in vitro diagnostics. 

For better understanding of the biochips market, the study comprises market attractiveness analysis, where the types of biochips are benchmarked based on their market scope, growth rate and market attractiveness. 

The report also provides company market share analysis of the various industry participants. Key players have been profiled and their company overview, financial overview, business strategies and recent developments have been covered in the report. Major market participants profiled in this report include Affymetrix Inc., Illumina Inc., GE Healthcare Ltd., Agilent Technologies Inc., Fluidigm Corporation and Cepheid Inc. among others.

The biochips market has been segmented as: 
– Global Biochips Market: By Type
DNA Chips
Protein Chips
Microfluidic Devices

– Global Biochips Market: By Application
Drug Discovery & Development
Genomics
Proteomics
In Vitro Diagnostics

– Global Biochips Market: By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
Italy
France
Germany
Rest of Europe
Asia Pacific
China
India
Japan
Rest of Asia Pacific
Rest of the World (RoW)
Latin America
U.A.E.
South Africa
Others

– Table of Contents

– Chapter 1 Preface
1.1 Report Description
1.2 Research Scope
1.3 Key Take away
1.4 Research Methodology

– Chapter 2 Executive Summary
Chapter 3 Global Overview
3.1 Introduction
3.2 Nature of the market
3.3 Market Drivers
3.3.1 Increasing investments in drug discovery and research, availability of molecular information
3.3.2 Possibility of automating processes
3.3.3 Compact biochips decrease production cost
3.4 Market Restraints
3.4.1 Stringent government regulations and standards
3.4.2 Fabrication of biochips
3.5 Market Opportunities
3.5.1 Emerging markets of Asia Pacific and Rest of the World (RoW)
3.5.2 Home monitoring biochips systems
3.6 Biochips Market: Market share of key players
3.6.1 Competitive strategies adopted by key players
3.7 Biochips Market: Market attractiveness analysis

– Chapter 4 Global Biochips Market: By Type
4.1 Overview
4.1.1 Global Biochips Market Revenue Share, By Type, 2014 – 2023 (%)
4.2 Global DNA Chips Market Revenue and Forecast, 2014 – 2023, (USD Million)
4.2 Global Protein Chips Market Revenue and Forecast, 2014 – 2023, (USD Million)
4.2 Global Microfluidic Devices Market Revenue and Forecast, 2014 – 2023, (USD Million)

– Chapter 5 Global Biochips Market: By Application
5.1 Overview
5.1.1 Global Biochips System Market Revenue Share, By Application, 2014 and 2023 (%)
5.2 Global Drug Discovery & DevelopmentMarket Revenue and Forecast, 2014 – 2023, (USD Million)
5.3 Global Genomics Market Revenue and Forecast, 2014 – 2023, (USD Million)
5.4 Global Proteomics Market Revenue and Forecast, 2014 – 2023, (USD Million)
5.5 Global In Vitro Diagnostics Market Revenue and Forecast, 2014 – 2023, (USD Million)

– Chapter 6 Global Biochips Market; By Geography
6.1 Overview
6.1.1 Global Biochips Market Revenue Share, By Geography, 2014 and 2023 (%)
6.2 North America Biochips Market, 2014 – 2023, (USD Million)
6.2.1 North America Biochips Market, By Type, 2014 – 2023, (USD Million)
6.2.2 North America Biochips Market, By Application, 2014 – 2023, (USD Million)
6.2.3 U.S. Biochips Market, 2014 – 2023, (USD Million)
6.2.3.1 U.S. Biochips Market, By Type, 2014 – 2023, (USD Million)

Full Report @ http://www.researchmoz.us/biochips-market-global-industry-analysis-size-share-growth-trends-and-forecast-2015-2023-report.html

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.